Trials / Completed
CompletedNCT03587415
Serum Preptin and Amylin Levels in Polycystic Ovary Syndrome Patients
Serum Preptin and Amylin Levels With Respect to Body Mass Index in Polycystic Ovary
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- Recep Tayyip Erdogan University Training and Research Hospital · Academic / Other
- Sex
- Female
- Age
- 17 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
Preptin and amylin are pancreatic hormones which participate in glucose homeostasis. This study aims to evaluate how serum preptin and amylin levels are altered in polycystic ovary syndrome (PCOS) patients and healthy women based on BMI groups .
Detailed description
Materials and Methods: This is a cross-sectional review of 40 PCOS patients and 40 healthy women who were matched with respect to BMI (\<25 kg/m2 and ≥25 kg/m2).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | preptin and amylin level | we will take both of group blood samples to compare them serum preptin and amylin |
Timeline
- Start date
- 2017-06-28
- Primary completion
- 2017-11-30
- Completion
- 2017-12-07
- First posted
- 2018-07-16
- Last updated
- 2018-07-16
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT03587415. Inclusion in this directory is not an endorsement.